Therefore, unlike other commercially available α-CD47 antibodies, we found that CC2C6-mAb in solution efficiently induced Jurkat T-ALL cell death in a CD47-dependent manner. The gene discussed is CD47; the disease is acute lymphoblastic leukemia.